Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Callan Jmb (CJMB) Shares Outstanding (Weighted Average) (2023 - 2025)

Callan Jmb (CJMB) has disclosed Shares Outstanding (Weighted Average) for 3 consecutive years, with $4.5 million as the latest value for Q3 2025.

  • Quarterly Shares Outstanding (Weighted Average) rose 79.21% to $4.5 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $4.5 million through Sep 2025, up 79.21% year-over-year, with the annual reading at $2.6 million for FY2024, 12.33% down from the prior year.
  • Shares Outstanding (Weighted Average) hit $4.5 million in Q3 2025 for Callan Jmb, up from $4.2 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $4.5 million in Q3 2025 to a low of $2.5 million in Q2 2024.
  • Historically, Shares Outstanding (Weighted Average) has averaged $3.2 million across 3 years, with a median of $2.8 million in 2023.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): decreased 12.33% in 2024 and later surged 79.21% in 2025.
  • Year by year, Shares Outstanding (Weighted Average) stood at $3.0 million in 2023, then fell by 12.33% to $2.6 million in 2024, then surged by 70.72% to $4.5 million in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for CJMB at $4.5 million in Q3 2025, $4.2 million in Q2 2025, and $3.9 million in Q1 2025.